Michael Aaron Kelly - Aug 10, 2023 Form 4 Insider Report for NEOGENOMICS INC (NEO)

Role
Director
Signature
/s/ Ali Olivo, Attorney-in-Fact
Stock symbol
NEO
Transactions as of
Aug 10, 2023
Transactions value $
$0
Form type
4
Date filed
8/14/2023, 05:40 PM
Previous filing
Jun 16, 2023
Next filing
May 15, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding NEO Common Stock 20.4K Aug 10, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NEO Stock Option (Right to Buy) Award $0 +8.35K $0.00 8.35K Aug 10, 2023 Common Stock 8.35K $14.82 Direct
transaction NEO Restricted Stock Unit Award $0 +11.3K $0.00 11.3K Aug 10, 2023 Common Stock 11.3K $0.00 Direct F1
holding NEO Stock Option (Right to Buy) 2.22K Aug 10, 2023 Common Stock 2.22K $37.53 Direct
holding NEO Stock Option (Right to Buy) 3.71K Aug 10, 2023 Common Stock 3.71K $40.90 Direct
holding NEO Stock Option (Right to Buy) 13.9K Aug 10, 2023 Common Stock 13.9K $8.10 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Once vested, the shares of common stock are not subject to expiration.